Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study. Cahn A, Mosenzon O, Wiviott SD, Rozenberg A, et al. Diabetes Care 2020;43:468-475.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cahn A, Mosenzon O, Wiviott SD, Rozenberg A, et al. Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study. Diabetes Care 2020;43:468-475.
PMID: 31843945